Tandem Diabetes Care Q1 2025 10-Q Filing
Ticker: TNDM · Form: 10-Q · Filed: Apr 30, 2025 · CIK: 1438133
| Field | Detail |
|---|---|
| Company | Tandem Diabetes Care Inc (TNDM) |
| Form Type | 10-Q |
| Filed Date | Apr 30, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, medical-devices
Related Tickers: PODD
TL;DR
**TNDM Q1 2025 10-Q FILED. FINANCIALS OUT.**
AI Summary
Tandem Diabetes Care, Inc. filed its quarterly report for the period ending March 31, 2025. The company, headquartered in San Diego, CA, is involved in the surgical and medical instruments and apparatus industry. Key financial data and operational details for the first quarter of 2025 are presented in this filing.
Why It Matters
This filing provides investors and analysts with the latest financial performance and operational updates for Tandem Diabetes Care, Inc. as of March 31, 2025.
Risk Assessment
Risk Level: medium — As a medical device company, Tandem Diabetes Care faces risks related to product development, regulatory approvals, market competition, and reimbursement policies.
Key Numbers
- N/A — Revenue (Specific revenue figures for Q1 2025 are not detailed in this header information.)
- N/A — Net Income (Specific net income figures for Q1 2025 are not detailed in this header information.)
- N/A — Earnings Per Share (Specific EPS figures for Q1 2025 are not detailed in this header information.)
Key Players & Entities
- TANDEM DIABETES CARE INC (company) — Filer
- San Diego, CA (location) — Business Address
- 20250331 (date) — Reporting Period End Date
- 20250430 (date) — Filing Date
FAQ
What were Tandem Diabetes Care's total revenues for the first quarter of 2025?
The provided header information does not contain specific revenue figures for the first quarter of 2025. The full 10-Q document would be needed for this detail.
Did Tandem Diabetes Care report a net profit or loss in the first quarter of 2025?
The header information does not specify the net income or loss for the first quarter of 2025. This detail would be found within the financial statements of the full 10-Q filing.
What is the company's primary business segment as indicated in the filing?
The company is classified under 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]'.
When was this 10-Q filing submitted to the SEC?
This 10-Q filing was submitted on April 30, 2025.
What is the fiscal year-end for Tandem Diabetes Care?
The company's fiscal year ends on December 31.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on April 30, 2025 regarding TANDEM DIABETES CARE INC (TNDM).